StockData
Artelo Biosciences, Inc. logo

Artelo Biosciences, Inc. (ARTL) stock

ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.50−0.18 (-10.71%)

Close on Nov 18, 2026Market cap $1.01MP/E –Yield –

Artelo Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Artelo Biosciences

Artelo Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Artelo Biosciences figures

See a number that looks wrong?